Resources Contact Us Home
Recombinant toxin fragments

Image Number 4 for United States Patent #8017134.

A single polypeptide is provided which comprises first and second domains. The first domain enables the polypeptide to cleave one or more vesicle or plasma-membrane associated proteins essential to exocytosis, and the second domain enables the polypeptide to be translocated into a target cell or increases the solubility of the polypeptide, or both. The polypeptide thus combines useful properties of a clostridial toxin, such as a botulinum or tetanus toxin, without the toxicity associated with the natural molecule. The polypeptide can also contain a third domain that targets it to a specific cell, rendering the polypeptide useful in inhibition of exocytosis in target cells. Fusion proteins comprising the polypeptide, nucleic acids encoding the polypeptide and methods of making the polypeptide are also provided. Controlled activation of the polypeptide is possible and the polypeptide can be incorporated into vaccines and toxin assays.

  Recently Added Patents
Encoding method and encoding device, decoding method and decoding device and transcoding method and transcoder for multi-object audio signals
Variable speed traffic control system
Decentralized processing network
Email certificates
Methods and apparatus to perform time zone determination by a mobile station
Camera with monitor
Transistor and display device
  Randomly Featured Patents
Actuators for valves for pressurized dispensers
Method and system for interactively responding to instant messaging requests
Clean grain and tailings conveying system for an agricultural combine
Two-faced golf club
Seamless two-way roadway communication system
Sulfonate salts and derivatives, photoacid generators, resist compositions, and patterning process
Low heat loss laser combustion chamber
Method for making silicon nitride powder
Semiconductor device and manufacturing method thereof
Portion of a vehicle vent outlet